CHINESE JOURNAL OF CANCER RESEARCH, cilt.29, sa.6, ss.521-532, 2017 (SCI-Expanded)
Objective: Primary uterine leiomyosarcomas (ULMS) are rare, and the optimal treatment is controversial. We aimed to assess the outcome and prognostic factors in a multicenter population of women treated for primary ULMS.